Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2003-10-06 / Br. J. Cancer 2003 Oct;89(7):1172-9Presence of functional dendritic cells in patients chronically infected with hepatitis C virus
/in Chronic Virus Hepatitis, International Publications /von 2003-10-02 / Blood 2004 Feb;103(3):1026-9Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study
/in Esophageal Carcinoma, International Publications /von 2003-10-01 / J. Hematother. Stem Cell Res. 2003 Oct;12(5):515-23Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2003-10-01 / Haematologica 2003 Oct;88(10):1139-49Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2003-10-01 / Melanoma Res. 2003 Oct;13(5):521-30Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells
/in Breast Cancer, Dendritic Cells, International Publications /von 2003-10-01 / Clin. Cancer Res. 2003 Oct;9(12):4376-86Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses
/in Chronic Virus Hepatitis, International Publications /von 2003-10-01 / J. Virol. 2003 Oct;77(20):10862-71IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de